Fecal microbiota transplantation: Review and update

Journal of the Formosan Medical Association

Volumn 118, Issue , 2019, Pages S23-S31

  Wang, Jiunn Wei ^a,b   Kuo, Chao Hung ^a,c,d   Kuo, Fu Chen ^e   Wang, Yao Kuang ^d   Hsu, Wen Hung ^a,c   Yu, Fang Jung ^a,c   Hu, Huang Ming ^b,c   Hsu, Ping I ^f   Wang, Jaw Yuan ^a   Wu, Deng Chyang ^a,c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^e I SHOU UNIVERSITY   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Fecal microbiota transplantation; Intestinal microbiota

Indexed keywords

CLOSTRIDIUM DIFFICILE INFECTION; DONOR SELECTION; ESOPHAGOGASTRODUODENOSCOPY; FECAL MICROBIOTA TRANSPLANTATION; GOVERNMENT REGULATION; HISTORY OF MEDICINE; HUMAN; INTESTINE FLORA; NONHUMAN; PATIENT MONITORING; PATIENT SAFETY; REVIEW; STOOL DONOR; TREATMENT CONTRAINDICATION; CLOSTRIDIUM INFECTION; GASTROINTESTINAL DISEASE; PEPTOCLOSTRIDIUM DIFFICILE; PRACTICE GUIDELINE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; TREATMENT OUTCOME; TRENDS;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL DISEASES; HUMANS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; TREATMENT OUTCOME;

EID: 85052759830     PISSN: 09296646     EISSN: 18760821     Source Type: Journal    
DOI: 10.1016/j.jfma.2018.08.011     Document Type: Review

References (76)

1. Duncan, S.H., Louis, P., Flint, H.J., Cultivable bacterial diversity from the human colon. Lett Appl Microbiol 44 (2007), 343–350.
2. Rashid, M.U., Zaura, E., Buijs, M.J., Keijser, B.J., Crielaard, W., Nord, C.E., et al. Determining the long-term effect of antibiotic administration on the human normal intestinal microbiota using culture and pyrosequencing methods. Clin Infect Dis 60:Suppl 2 (2015), S77–S84.
3. Chang, J.Y., Antonopoulos, D.A., Kalra, A., Tonelli, A., Khalife, W.T., Schmidt, T.M., et al. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 197 (2008), 435–438.
4. Tamburini, S., Shen, N., Wu, H.C., Clemente, J.C., The microbiome in early life: implications for health outcomes. Nat Med 22 (2016), 713–722.
5. Kernbauer, E., Ding, Y., Cadwell, K., An enteric virus can replace the beneficial function of commensal bacteria. Nature 516 (2014), 94–98.
6. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
7. Abdollahi-Roodsaz, S., Abramson, S.B., Scher, J.U., The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions. Nat Rev Rheumatol 12 (2016), 446–455.
8. Collado, M.C., Rautava, S., Isolauri, E., Salminen, S., Gut microbiota: a source of novel tools to reduce the risk of human disease?. Pediatr Res 77 (2015), 182–188.
9. Gupta, A., Khanna, S., Fecal microbiota transplantation. JAMA, 318, 2017, 102.
10. Surawicz, C.M., Brandt, L.J., Binion, D.G., Ananthakrishnan, A.N., Curry, S.R., Gilligan, P.H., et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108 (2013), 478–498 quiz 99.
11. Kelly, C.R., Ihunnah, C., Fischer, M., Khoruts, A., Surawicz, C., Afzali, A., et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol 109 (2014), 1065–1071.
12. Agrawal, M., Aroniadis, O.C., Brandt, L.J., Kelly, C., Freeman, S., Surawicz, C., et al. The long-term efficacy and safety of fecal microbiota transplant for recurrent, severe, and complicated Clostridium difficile infection in 146 elderly individuals. J Clin Gastroenterol 50 (2016), 403–407.
13. Khoruts, A., Rank, K.M., Newman, K.M., Viskocil, K., Vaughn, B.P., Hamilton, M.J., et al. Inflammatory bowel disease affects the outcome of fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol 14 (2016), 1433–1438.
14. Smith, M.B., Kelly, C., Alm, E.J., Policy: how to regulate faecal transplants. Nature 506 (2014), 290–291.
15. Zhang, F., Luo, W., Shi, Y., Fan, Z., Ji, G., Should we standardize the 1,700-year-old fecal microbiota transplantation?. Am J Gastroenterol, 107, 2012, 1755 author reply p -6.
16. Eiseman, B., Silen, W., Bascom, G.S., Kauvar, A.J., Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44 (1958), 854–859.
17. Brandt, L.J., Aroniadis, O.C., Mellow, M., Kanatzar, A., Kelly, C., Park, T., et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 107 (2012), 1079–1087.
18. Borody, T.J., Warren, E.F., Leis, S.M., Surace, R., Ashman, O., Siarakas, S., Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol 38 (2004), 475–483.
19. van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E.G., de Vos, W.M., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368 (2013), 407–415.
20. Borody, T.J., George, L., Andrews, P., Brandl, S., Noonan, S., Cole, P., et al. Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome?. Med J Aust, 150, 1989, 604.
21. Smits, L.P., Bouter, K.E., de Vos, W.M., Borody, T.J., Nieuwdorp, M., Therapeutic potential of fecal microbiota transplantation. Gastroenterology 145 (2013), 946–953.
22. Khoruts, A., Dicksved, J., Jansson, J.K., Sadowsky, M.J., Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 44 (2010), 354–360.
23. Hamilton, M.J., Weingarden, A.R., Sadowsky, M.J., Khoruts, A., Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 107 (2012), 761–767.
24. Gough, E., Shaikh, H., Manges, A.R., Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 53 (2011), 994–1002.
25. Kassam, Z., Lee, C.H., Yuan, Y., Hunt, R.H., Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 108 (2013), 500–508.
26. U.S. Food and Drug Administration. Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies.
27. Borody, T.J., Warren, E.F., Leis, S., Surace, R., Ashman, O., Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 37 (2003), 42–47.
28. Kunde, S., Pham, A., Bonczyk, S., Crumb, T., Duba, M., Conrad, H. Jr., et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr 56 (2013), 597–601.
29. Kao, D., Hotte, N., Gillevet, P., Madsen, K., Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial profile. J Clin Gastroenterol 48 (2014), 625–628.
30. Paramsothy, S., Kamm, M.A., Kaakoush, N.O., Walsh, A.J., van den Bogaerde, J., Samuel, D., et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 389 (2017), 1218–1228.
31. Cui, B., Li, P., Xu, L., Zhao, Y., Wang, H., Peng, Z., et al. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J Transl Med, 13, 2015, 298.
32. Zhang, T., Xiang, J., Cui, B., He, Z., Li, P., Chen, H., et al. Cost-effectiveness analysis of fecal microbiota transplantation for inflammatory bowel disease. Oncotarget 8 (2017), 88894–88903.
33. Varier, R.U., Biltaji, E., Smith, K.J., Roberts, M.S., Kyle Jensen, M., LaFleur, J., et al. Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection. Infect Control Hosp Epidemiol 36 (2015), 438–444.
34. Ford, A.C., Spiegel, B.M., Talley, N.J., Moayyedi, P., Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol 7 (2009), 1279–1286.
35. Hoveyda, N., Heneghan, C., Mahtani, K.R., Perera, R., Roberts, N., Glasziou, P., A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol, 9, 2009, 15.
36. Tian, H., Ding, C., Gong, J., Ge, X., McFarland, L.V., Gu, L., et al. Treatment of slow transit constipation with fecal microbiota transplantation: a pilot study. J Clin Gastroenterol 50 (2016), 865–870.
37. Backhed, F., Manchester, J.K., Semenkovich, C.F., Gordon, J.I., Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 104 (2007), 979–984.
38. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
39. Ley, R.E., Backhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102 (2005), 11070–11075.
40. Vrieze, A., Van Nood, E., Holleman, F., Salojarvi, J., Kootte, R.S., Bartelsman, J.F., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143 (2012), 913–916, e7.
41. Xu, M.Q., Cao, H.L., Wang, W.Q., Wang, S., Cao, X.C., Yan, F., et al. Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J Gastroenterol 21 (2015), 102–111.
42. Aroniadis, O.C., Brandt, L.J., Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol 29 (2013), 79–84.
43. Crum-Cianflone, N.F., Sullivan, E., Ballon-Landa, G., Fecal microbiota transplantation and successful resolution of multidrug-resistant-organism colonization. J Clin Microbiol 53 (2015), 1986–1989.
44. McClave, S.A., Patel, J., Bhutiani, N., Should fecal microbial transplantation be used in the ICU?. Curr Opin Crit Care 24 (2018), 105–111.
45. Gopalakrishnan, V., Spencer, C.N., Nezi, L., Reuben, A., Andrews, M.C., Karpinets, T.V., et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359 (2018), 97–103.
46. Routy, B., Le Chatelier, E., Derosa, L., Duong, C.P.M., Alou, M.T., Daillere, R., et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359 (2018), 91–97.
47. Choi, H.H., Cho, Y.S., Fecal microbiota transplantation: current applications, effectiveness, and future perspectives. Clin Endosc 49 (2016), 257–265.
48. Bakker, G.J., Nieuwdorp, M., Fecal microbiota transplantation: therapeutic potential for a multitude of diseases beyond Clostridium difficile. Microbiol Spectr, 5, 2017.
49. Cammarota, G., Ianiro, G., Tilg, H., Rajilic-Stojanovic, M., Kump, P., Satokari, R., et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut 66 (2017), 569–580.
50. Bakken, J.S., Borody, T., Brandt, L.J., Brill, J.V., Demarco, D.C., Franzos, M.A., et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 9 (2011), 1044–1049.
51. Paramsothy, S., Borody, T.J., Lin, E., Finlayson, S., Walsh, A.J., Samuel, D., et al. Donor recruitment for fecal microbiota transplantation. Inflamm Bowel Dis 21 (2015), 1600–1606.
52. Vindigni, S.M., Surawicz, C.M., Fecal microbiota transplantation. Gastroenterol Clin N Am 46 (2017), 171–185.
53. Weingarden, A.R., Chen, C., Bobr, A., Yao, D., Lu, Y., Nelson, V.M., et al. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol 306 (2014), G310–G319.
54. Shankar, V., Hamilton, M.J., Khoruts, A., Kilburn, A., Unno, T., Paliy, O., et al. Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation. Microbiome, 2, 2014, 13.
55. Kelly, C.R., Kahn, S., Kashyap, P., Laine, L., Rubin, D., Atreja, A., et al. Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology 149 (2015), 223–237.
56. Sokol, H., Galperine, T., Kapel, N., Bourlioux, P., Seksik, P., Barbut, F., et al. Faecal microbiota transplantation in recurrent Clostridium difficile infection: recommendations from the French Group of Faecal microbiota Transplantation. Dig Liver Dis 48 (2016), 242–247.
57. Tang, G., Yin, W., Liu, W., Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: a meta-analysis?. Diagn Microbiol Infect Dis 88 (2017), 322–329.
58. Lee, C.H., Steiner, T., Petrof, E.O., Smieja, M., Roscoe, D., Nematallah, A., et al. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial. JAMA 315 (2016), 142–149.
59. Wise, J., Frozen faecal matter works as well as fresh for transplantation in C difficile patients. BMJ, 352, 2016, i138.
60. Blackburn, L.M., Bales, A., Caldwell, M., Cordell, L., Hamilton, S., Kreider, H., Fecal microbiota transplantation in patients with cancer undergoing treatment. Clin J Oncol Nurs 19 (2015), 111–114.
61. Evrensel, A., Ceylan, M.E., Fecal microbiota transplantation and its usage in neuropsychiatric disorders. Clin Psychopharmacol Neurosci 14 (2016), 231–237.
62. Goldenberg, S.D., Batra, R., Beales, I., Digby-Bell, J.L., Irving, P.M., Kellingray, L., et al. Comparison of different strategies for providing fecal microbiota transplantation to treat patients with recurrent Clostridium difficile infection in two English Hospitals: a review. Infect Dis Ther 7 (2018), 71–86.
63. Brandt, L.J., Aroniadis, O.C., An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointest Endosc 78 (2013), 240–249.
64. Orenstein, R., Dubberke, E., Hardi, R., Ray, A., Mullane, K., Pardi, D.S., et al. Safety and durability of RBX2660 (microbiota suspension) for recurrent Clostridium difficile infection: results of the PUNCH CD study. Clin Infect Dis 62 (2016), 596–602.
65. Dubberke, E.R., Lee, C.H., Orenstein, R., Khanna, S., Hecht, G., Gerding, D.N., Results from a randomized placebo-controlled clinical trial of a RBX2660-a microbiota-based drug for the prevention of recurrent Clostridium difficile infection. Clin Infect Dis, 2018.
66. Cammarota, G., Ianiro, G., Gasbarrini, A., Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol 48 (2014), 693–702.
67. Youngster, I., Sauk, J., Pindar, C., Wilson, R.G., Kaplan, J.L., Smith, M.B., et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis 58 (2014), 1515–1522.
68. Kao, D., Roach, B., Silva, M., Beck, P., Rioux, K., Kaplan, G.G., et al. Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: a randomized clinical trial. JAMA 318 (2017), 1985–1993.
69. Emanuelsson, F., Claesson, B.E., Ljungstrom, L., Tvede, M., Ung, K.A., Faecal microbiota transplantation and bacteriotherapy for recurrent Clostridium difficile infection: a retrospective evaluation of 31 patients. Scand J Infect Dis 46 (2014), 89–97.
70. Mattila, E., Uusitalo-Seppala, R., Wuorela, M., Lehtola, L., Nurmi, H., Ristikankare, M., et al. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 142 (2012), 490–496.
71. Rossen, N.G., MacDonald, J.K., de Vries, E.M., D'Haens, G.R., de Vos, W.M., Zoetendal, E.G., et al. Fecal microbiota transplantation as novel therapy in gastroenterology: a systematic review. World J Gastroenterol 21 (2015), 5359–5371.
72. De Leon, L.M., Watson, J.B., Kelly, C.R., Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol 11 (2013), 1036–1038.
73. Fischer, M., Kao, D., Kelly, C., Kuchipudi, A., Jafri, S.M., Blumenkehl, M., et al. Fecal microbiota transplantation is safe and efficacious for recurrent or refractory Clostridium difficile infection in patients with inflammatory bowel disease. Inflamm Bowel Dis 22 (2016), 2402–2409.
74. Quera, R., Espinoza, R., Estay, C., Rivera, D., Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection. J Crohns Colitis 8 (2014), 252–253.
75. Allen-Vercoe, E., Reid, G., Viner, N., Gloor, G.B., Hota, S., Kim, P., et al. A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics. Can J Gastroenterol 26 (2012), 457–462.
76. Khanna, S., Microbiota replacement therapies: innovation in gastrointestinal care. Clin Pharmacol Ther 103 (2018), 102–111.